• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Emerg Microbes Infect . A single N342D substitution in influenza B Virus NA protein determines viral pathogenicity in mice

tetano

Editor, Senior Moderator
Emerg Microbes Infect


. 2020 Aug 4;1-35.
doi: 10.1080/22221751.2020.1806005. Online ahead of print.
A single N342D substitution in influenza B Virus NA protein determines viral pathogenicity in mice


Lijuan Zhou[SUP] 1 2 [/SUP], Zhaomin Feng[SUP] 2 [/SUP], Jia Liu[SUP] 2 [/SUP], Yongkun Chen[SUP] 1 [/SUP], Lei Yang[SUP] 2 [/SUP], Suli Liu[SUP] 1 [/SUP], Xiyan Li[SUP] 2 [/SUP], Rongbao Gao[SUP] 2 [/SUP], Wenfei Zhu[SUP] 2 [/SUP], Dayan Wang[SUP] 2 [/SUP], Yuelong Shu[SUP] 1 2 [/SUP]



Affiliations

Abstract

Influenza B virus (IBV) is one of the most important human respiratory viruses: it causes approximately one-third of the global influenza-related disease burden each year. However, compared with the several pathogenicity-related molecular markers that have been identified for influenza A virus (IAV), little is known about potential IBV pathogenicity-related markers. Here, although the IBV strain B/Anhui-Tunxi/1528/2014 (AH1528/14) exhibited a more efficient replication ability in vitro and higher pathogenicity in vivo compared with IBV strain B/Anhui-Baohe/127/2015 (AH127/15), only three amino acids differences (HA[SUB]A390E[/SUB], NA[SUB]N342D[/SUB] and PB1[SUB]V212I[/SUB]) were observed among their full genomes. The contributions of each amino acid difference to the virus pathogenicity were further investigated. Compared with the wild type IBV virus rAH127, the recombinant virus harbouring a single substitution of HA[SUB]A390E[/SUB] had a similar phenotype, whereas the recombinant virus harbouring PB1[SUB]V212I[/SUB] replicated to a moderately higher titre in both MDCK cells and in mice. Notably, the virus harbouring NA[SUB]N342D[/SUB] showed significantly better growth properties in MDCK cells and higher fatality rates in mice. In addition, the presence of NA[SUB]N342D[/SUB] dramatically enhanced the viral neuraminidase activity. In conclusion, our study identified a novel IBV molecular marker, NA[SUB]N342D[/SUB], that could significantly increase the virulence of IBV in mice.

Keywords: Influenza B virus (IBV); molecular marker; neuraminidase; pathogenicity.
 
Back
Top Bottom